Setit, Irene .
HRN: 07-30-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2023
CEFUROXIME 500MG (TAB)
01/20/2023
01/27/2023
ORAL
500mg/tab
BID
S/P NSVD With Hyperthyroidism
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes